OBJECTIVE: 1) Review our institutional experience of the management of subglottic hemangiomas. 2) Evaluate the effi-cacy of propranolol as first-line treatment for infantile subglottic hemangiomas. METHOD: We present a retrospective chart review of infantile subglottic hemangiomas over a 5-year span (January 2005-January 2010) at a tertiary care pediatric hospital. IRB approval was obtained, and charts were reviewed to find patients with subglottic hemagiomas, including patient characteristics, presentation, workup, medical and surgical management, and outcomes. A case presentation is made of a recently diagnosed subglottic hemangioma, demonstrating diagnostic, management, and treatment strategies and dilemmas encountered. RESULTS: Over the past five years at our institution, nine patients were found to have infantile subglottic hemangiomas. Six of nine patients were treated with laser excision, with five of the six having localized subglottic hemangiomas. In 2009, three of four patients were initiated on Propranolol as first-line treatment; the fourth had comorbidities which precluded this. Of the three, one showed improvement with resolution of stridor. A second patient, who also had bearded hemangioma, went on to require tracheotomy, while a third required prolonged treatment with steroids. CONCLUSION: Infantile subglottic hemangiomas are rare but essential in the differential diagnosis of biphasic stridor. Although Propranolol has been effective in treating cutaneous and airway hemangiomas, our experience suggests that this is not consistent in the case of subglottic hemangiomas. In an area where airway compromise can be lethal, we must extend caution and monitor these patients closely as they may require adjuvant therapy.
Propranolol in the Treatment of Subglottic Hemangiomas
Lauren Anderson de Moreno, MD (presenter); Bruce Matt, MD, MS; David Horn, MD; Young-Jee Kim, MD; Gregory Montgomery, MD OBJECTIVE: Evaluate propranolol as an effective initial treatment of upper airway hemangioma causing significant obstruction symptoms. METHOD: Medical records of 4 pediatric patients with airway hemangioma (glottis and subglottic) treated with propranolol at a tertiary care children's hospital were reviewed retrospectively from August 2008-January 2010. RESULTS: All 4 patients were 2 months of age at the time of hemangioma diagnosis, and had stridor and physical signs of severe upper airway obstruction. Hemangioma was diagnosed by flexible laryngoscopy or flexible bronchoscopy. All patients received propranolol 2mg/kg/day and showed a significant relief of obstruction symptoms in 24 hours after initiating the treatment. All patients tolerated propranolol without significant cardiovascular complications. CONCLUSION: We report the clinical response of glottis and subglottic hemangiomas to propranolol. Propranolol may be a
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